CEO
Melanie I. Nallicheri
Employees
240
Industry
Research and Development in Biotechnology
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
November 08, 2023 | 4:33 pm
Portfolio Pulse from Charles Gross
August 04, 2023 | 2:44 pm
Portfolio Pulse from Lisa Levin
August 04, 2023 | 10:08 am
Portfolio Pulse from Benzinga Newsdesk
August 04, 2023 | 9:58 am
Portfolio Pulse from Benzinga Insights
August 04, 2023 | 9:54 am
Portfolio Pulse from Vandana Singh
August 04, 2023 | 9:45 am
Portfolio Pulse from Benzinga Insights
August 01, 2023 | 2:25 pm
Portfolio Pulse from Charles Gross
August 01, 2023 | 11:33 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.